Sustained Leadership for Continued Advancement

The Campus Bio-Medico Polyclinic Foundation is maintaining a steady course with the reconfirmation of Carlo tosti as President and paolo Sormani as CEO and General Manager. This decision ensures continuity in leadership as the Foundation embarks on a new three-year term, set to conclude with the approval of the final balance sheet in 2027.

Bolstering the Board: New Expertise for Future Initiatives

Alongside Tosti and Sormani, returning council members Fabio Giuseppe Angelini, Chiara Fiorani, and Stefano Piccaluga will continue their service.The Board of Directors welcomes two new members: Guido Costamagna, a distinguished Professor of General Surgery at the Catholic University of the Sacred Heart of Rome and a specialist in digestive endoscopy, and Anna Maria Ferraresi, an HR Business Partner at Ferrero, bringing extensive experience in human resources. These strategic appointments are designed to enhance the Board’s collective expertise, facilitating the consolidation of existing activities and the development of innovative projects.

Strategic Focus: Health, Training, and Cutting-Edge Research

The Institute, in close collaboration with the Campus Bio-Medico University of Rome, is committed to furthering its progress in health, training, and research. A key emphasis will be placed on technological innovation and achieving accreditation as an Institution of Hospitalization and Treatment (IRCCS), specifically for pathologies related to the locomotor apparatus. This accreditation signifies a commitment to excellence and positions the Polyclinic as a leader in specialized medical care [[1]].

Leadership Perspectives on Future Goals

Carlo Tosti expressed his gratitude for the renewed confidence, stating, Thank you for the confirmation of the presidency and for the possibility of continuing to work on projects already started and on new initiatives. The IRCCS accreditation is an critically important challenge for the next few years, as well as the strengthening of the activities that center the person and his needs.

Paolo Sormani added, We continue the work to consolidate the role of the Polyclinic as a health garrison rooted in the area, oriented towards innovation and attentive to the social dimension. in addition to technological and infrastructure investments, we intend to enhance initiatives such as the friend tariff, which allows users to access performance at subsidized costs. The “friend tariff” exemplifies the Polyclinic’s commitment to accessible healthcare, a growing need in Italy where, according to recent statistics, out-of-pocket healthcare expenses have been steadily increasing.

Commitment to Responsible Growth

The new Council conveyed their gratitude to the outgoing members for their contributions during the previous term. They affirmed their dedication to responsibly managing the Institute’s activities throughout the 2025-2027 period. This commitment aligns with the Polyclinic’s ongoing efforts to maintain high standards of quality and safety, as evidenced by its adherence to over 1300 measurable standards and its Academic Medical Center Hospital Accreditation [[3]].